Argiris Symeonidis

Professor of Hematology, Head of the Department

University of Patras School of Medicine

Greece

Research Interests

Explore related searches

Professors in Immunology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (19)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (18)

María Díez Campelo

Universidad de Salamanca

SPAIN

View details

Donald Arnold

Professor

McMaster University

CANADA

View details

Evangelia Farmaki

Aristotle University of Thessaloniki

GREECE

View details

Jeremy Jacobs

Assistant Professor

Vanderbilt University Medical Center

UNITED STATES

View details

Matthaios Speletas

University of Thessaly

GREECE

View details

Pawel Robak

Medical University of Lodz

POLAND

View details

Sinisa Savic

Clinical Associate Professor

University of Leeds

UNITED KINGDOM

View details

Meredith G. Parsons

Clinical Assistant Professor

University of Iowa Hospitals and Clinics

UNITED STATES

View details

Robert Orlowski

Florence Maude Thomas Cancer Research Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Panagiotis Τ. Diamantopoulos

National and Kapodistrian University of Athens

GREECE

View details

Anastasios Germenis

University of Thessaly Faculty of Medicine

GREECE

View details

Evangelos Terpos

Professor of Hematology

National and Kapodistrian University of Athens - Faculty of Medicine

GREECE

View details

Pieter Sonneveld

NETHERLANDS

View details

Christos Hadjichristodoulou

Professor of Hygiene and epidemilogy

University of Thessaly

GREECE

View details

Dariusz Woszczyk

Head of Department

Opole University

POLAND

View details

lionel adès

Professor

FRANCE

View details

Achilles Anagnostopoulos

Chief Scientific Director

GREECE

View details

Charalampos Pontikoglou

Associate Professor of Hematology

University of Crete

GREECE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Argiris Symeonidis

Research Interests

Explore related searches

Contact this professor

Articles (19)

Ixazomib plus daratumumab and dexamethasone: Final analysis of a phase 2 study among patients with relapsed/refractory multiple myeloma

The seasonal distribution of immune thrombotic thrombocytopenic purpura is influenced by geography: Epidemiologic findings from a multi‐center analysis of 719 disease episodes

Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee

Inflammatory profile of lower risk myelodysplastic syndromes

A Nationwide Study of the Delayed Diagnosis and the Clinical Manifestations of Predominantly Antibody Deficiencies and <i>CTLA4</i>-Mediated Immune Dysregulation Syndrome in Greece

Delayed diagnosis of a primary diffuse large B-cell lymphoma of the humeral head, presenting as pathological fracture: a case report and review of the literature

Autophagy and oxidative stress modulation mediate Bortezomib resistance in prostate cancer

Increased age-associated B cells in patients with acquired aplastic anemia correlate with IFN-γ

Real-Life Multicenter Experience of Venetoclax in Combination with Hypomethylating Agents in Previously Untreated Adult Patients with Acute Myeloid Leukemia in Greece

Prospective phase 2 trial of daratumumab with dexamethasone in patients with relapsed/refractory multiple myeloma and severe renal impairment or on dialysis: The DARE study

The prognostic significance of macrocytosis in patients with myelodysplastic neoplasms

Cause of death and excess mortality in patients with lower‐risk myelodysplastic syndromes (MDS): A report from the European MDS registry

Bone Marrow Immune Microenvironment in Myelodysplastic Syndromes

Pevonedistat plus azacitidine vs azacitidine alone in higher-risk MDS/chronic myelomonocytic leukemia or low-blast-percentage AML

Health‐related quality of life in patients with relapsed/refractory multiple myeloma treated with pomalidomide and dexamethasone ± subcutaneous daratumumab: Patient‐reported outcomes from the APOLLO trial

Bone marrow ribonucleotide reductase mRNA levels and methylation status as prognostic factors in patients with myelodysplastic syndrome treated with 5-Azacytidine

Core set of patient-reported outcomes for myelodysplastic syndromes: an EUMDS Delphi study involving patients and hematologists

Chronic Neutrophilic Leukemia: A Comprehensive Review of Clinical Characteristics, Genetic Landscape and Management

Daratumumab Improves Bone Turnover in Relapsed/Refractory Multiple Myeloma; Phase 2 Study "REBUILD"

Collaborators (18)

María Díez Campelo

Donald Arnold

Evangelia Farmaki

Jeremy Jacobs

Matthaios Speletas

Pawel Robak

Sinisa Savic

Meredith G. Parsons

Robert Orlowski

Panagiotis Τ. Diamantopoulos

Anastasios Germenis

Evangelos Terpos

Pieter Sonneveld

Christos Hadjichristodoulou

Dariusz Woszczyk

lionel adès

Achilles Anagnostopoulos

Charalampos Pontikoglou

Make your next move.